120 related articles for article (PubMed ID: 38871968)
41. Targeting of MNK/eIF4E overcomes chemoresistance in cervical cancer.
Zhu Y; Wang C; Li M; Yang X
J Pharm Pharmacol; 2021 Sep; 73(10):1418-1426. PubMed ID: 34254647
[TBL] [Abstract][Full Text] [Related]
42. MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.
Xu J; Ma X; Yang H; Zhang J; Cai G; Yao N
Chem Pharm Bull (Tokyo); 2021; 69(4):325-332. PubMed ID: 33790078
[TBL] [Abstract][Full Text] [Related]
43. Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.
Tamada M; Nagano O; Tateyama S; Ohmura M; Yae T; Ishimoto T; Sugihara E; Onishi N; Yamamoto T; Yanagawa H; Suematsu M; Saya H
Cancer Res; 2012 Mar; 72(6):1438-48. PubMed ID: 22293754
[TBL] [Abstract][Full Text] [Related]
44. Interaction between SCP3 and JAB1 Confers Cancer Therapeutic Resistance and Stem-like Properties through EGF Expression.
Oh SJ; Noh KH; Song KH; Kim TW
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445562
[TBL] [Abstract][Full Text] [Related]
45. Hepatocellular carcinoma cell-derived extracellular vesicles encapsulated microRNA-584-5p facilitates angiogenesis through PCK1-mediated nuclear factor E2-related factor 2 signaling pathway.
Shao Z; Pan Q; Zhang Y
Int J Biochem Cell Biol; 2020 Aug; 125():105789. PubMed ID: 32522621
[TBL] [Abstract][Full Text] [Related]
46. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
[TBL] [Abstract][Full Text] [Related]
47. Targeting lncRNA16 by GalNAc-siRNA conjugates facilitates chemotherapeutic sensibilization via the HBB/NDUFAF5/ROS pathway.
Liu Y; Wang Y; Liu B; Liu W; Ma Y; Cao Y; Yan S; Zhang P; Zhou L; Zhan Q; Wu N
Sci China Life Sci; 2024 Apr; 67(4):663-679. PubMed ID: 38155279
[TBL] [Abstract][Full Text] [Related]
48. Macrophages with a deletion of the
Ko CW; Counihan D; Wu J; Hatzoglou M; Puchowicz MA; Croniger CM
J Biol Chem; 2018 Mar; 293(9):3399-3409. PubMed ID: 29317502
[TBL] [Abstract][Full Text] [Related]
49. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting
Pandey P; Khan F; Alzahrani FA; Qari HA; Oves M
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577000
[TBL] [Abstract][Full Text] [Related]
50. Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression.
Meng Q; Sun H; Zhang Y; Yang X; Hao S; Liu B; Zhou H; Xu ZX; Wang Y
J Exp Clin Cancer Res; 2024 Jan; 43(1):36. PubMed ID: 38291438
[TBL] [Abstract][Full Text] [Related]
51. Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.
Zhao H; Duan Q; Zhang Z; Li H; Wu H; Shen Q; Wang C; Yin T
J Cell Mol Med; 2017 Sep; 21(9):2055-2067. PubMed ID: 28244691
[TBL] [Abstract][Full Text] [Related]
52. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
Sun Y; Gu X; Zhang E; Park MA; Pereira AM; Wang S; Morrison T; Li C; Blenis J; Gerbaudo VH; Henske EP; Yu JJ
Cell Death Dis; 2014 May; 5(5):e1231. PubMed ID: 24832603
[TBL] [Abstract][Full Text] [Related]
53. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression.
Poljak-Blazi M; Jaganjac M; Sabol I; Mihaljevic B; Matovina M; Grce M
Toxicol In Vitro; 2011 Feb; 25(1):160-6. PubMed ID: 21044880
[TBL] [Abstract][Full Text] [Related]
54. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers.
Rashmi R; Jayachandran K; Zhang J; Menon V; Muhammad N; Zahner M; Ruiz F; Zhang S; Cho K; Wang Y; Huang X; Huang Y; McCormick ML; Rogers BE; Spitz DR; Patti GJ; Schwarz JK
Mol Cancer Ther; 2020 Dec; 19(12):2465-2475. PubMed ID: 33087507
[TBL] [Abstract][Full Text] [Related]
55. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
Yuan X; Dong D; Li Z; Wu B
Pharmacol Res; 2019 Mar; 141():310-318. PubMed ID: 30639375
[TBL] [Abstract][Full Text] [Related]
56. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.
Lucarelli G; Galleggiante V; Rutigliano M; Sanguedolce F; Cagiano S; Bufo P; Lastilla G; Maiorano E; Ribatti D; Giglio A; Serino G; Vavallo A; Bettocchi C; Selvaggi FP; Battaglia M; Ditonno P
Oncotarget; 2015 May; 6(15):13371-86. PubMed ID: 25945836
[TBL] [Abstract][Full Text] [Related]
57. Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.
Ren M; Wang L; Gao ZX; Deng XY; Shen KJ; Li YL; Ding YT; Wei CY; Gu JY
Bioengineered; 2022 May; 13(5):13571-13586. PubMed ID: 36700470
[TBL] [Abstract][Full Text] [Related]
58. Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells.
Regmi S; Fung TS; Lim S; Luo KQ
Breast Cancer Res Treat; 2018 Nov; 172(2):297-312. PubMed ID: 30117065
[TBL] [Abstract][Full Text] [Related]
59. Glycogen synthase kinase-3β inactivation promotes cervical cancer progression, invasion, and drug resistance.
Nath N; Rana A; Nagini S; Mishra R
Biotechnol Appl Biochem; 2022 Oct; 69(5):1929-1941. PubMed ID: 34554598
[TBL] [Abstract][Full Text] [Related]
60. Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors.
Li Y; Luo S; Ma R; Liu J; Xu P; Zhang H; Tang K; Ma J; Zhang Y; Liang X; Sun Y; Ji T; Wang N; Huang B
Cancer Res; 2015 Apr; 75(7):1191-6. PubMed ID: 25712344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
